PeptideNerds

PT-141

Other FDA Approved strong evidence Track This Protocol
Alejandro Reyes

Written by Alejandro Reyes

Founder & Lead Researcher

PN

Reviewed by Peptide Nerds Editorial · Updated April 2026

Key Takeaway

PT-141 (Bremelanotide) is FDA-approved for hypoactive sexual desire disorder in women. It works through the melanocortin system rather than the vascular system like Viagra.

Quick Facts
Type Other
FDA Status FDA Approved
Evidence Level Strong
Typical Dose 1.75 mg per use
Frequency As needed, at least 45 min before activity
Key Goals

How it works

Activates melanocortin-4 receptors in the brain to increase sexual desire through central nervous system pathways.

Benefits

  • FDA-approved for HSDD in women
  • Works through desire pathway (not vascular)
  • Effective in both men and women

Side effects

  • Nausea (most common)
  • Flushing
  • Headache
  • Skin darkening

Dosing protocol

Typical Dose

1.75 mg per use

Frequency

As needed, at least 45 min before activity

FDA-approved as Vyleesi. Max 8 doses per month.

Deeper on PT-141

Full breakdowns of every part of the PT-141 research base.

What you will need

Basic supplies for reconstitution and subcutaneous injection.

This page contains affiliate links. Learn more

Get the PT-141 cheat sheet

Dosing quick-reference, key studies, and side effect management — in your inbox.

FDA status

FDA Approved for: Hypoactive sexual desire disorder in premenopausal women (Vyleesi)

Get the PT-141 cheat sheet

Dosing quick-reference, key studies, and side effect management — in your inbox.

Compare PT-141

Stacks with PT-141

Goals

Related peptides

Looking for weight loss peptides? See our complete guide to the best peptides for weight loss or compare semaglutide vs tirzepatide .

Get the Peptide Starter Kit (free)

Quick-start guide to GLP-1 peptides, dosing basics, and what to ask your doctor.

Medical Disclaimer: This content is for informational and educational purposes only. It is not intended as medical advice or a substitute for professional medical consultation, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any peptide protocol.